Alpha Radiation Emitters Device for the Treatment of Squamous Cell Carcinoma (DaRT)
A Safety and Effectiveness Study of Intratumoral Diffusing Alpha Radiation Emitters on Squamous Cell Carcinoma (First in Man)
Sponsor: Alpha Tau Medical LTD.
A NA clinical study on Squamous Cell Carcinoma, this trial is completed. The trial is conducted by Alpha Tau Medical LTD. and has accumulated 12 data snapshots since 2017. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
12 versions recorded-
Sep 2025 — Present [monthly]
Completed NA
-
Sep 2024 — Sep 2025 [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Feb 2021 — Jul 2024 [monthly]
Completed NA
-
Jan 2021 — Feb 2021 [monthly]
Completed NA
▶ Show 7 earlier versions
-
Jan 2020 — Jan 2021 [monthly]
Completed NA
-
Jul 2019 — Jan 2020 [monthly]
Completed NA
Status: Recruiting → Completed
-
Dec 2018 — Jul 2019 [monthly]
Recruiting NA
-
Jul 2018 — Dec 2018 [monthly]
Recruiting NA
Phase: PHASE1_PHASE2 → NA
-
Jun 2018 — Jul 2018 [monthly]
Recruiting PHASE1_PHASE2
-
Sep 2017 — Jun 2018 [monthly]
Recruiting PHASE1_PHASE2
Status: Not Yet Recruiting → Recruiting · Phase: PHASE3 → PHASE1_PHASE2
-
Feb 2017 — Sep 2017 [monthly]
Not Yet Recruiting PHASE3
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Alpha Tau Medical LTD.
For direct contact, visit the study record on ClinicalTrials.gov .